Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

UNITED THERAPEUTICS (UTHR) Inventory Average: 2010-2025

Historic Inventory Average for UNITED THERAPEUTICS (UTHR) over the last 15 years, with Sep 2025 value amounting to $172.8 million.

  • UNITED THERAPEUTICS's Inventory Average rose 22.07% to $172.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $172.8 million, marking a year-over-year increase of 22.07%. This contributed to the annual value of $134.8 million for FY2024, which is 26.15% up from last year.
  • As of Q3 2025, UNITED THERAPEUTICS's Inventory Average stood at $172.8 million, which was up 3.32% from $167.3 million recorded in Q2 2025.
  • In the past 5 years, UNITED THERAPEUTICS's Inventory Average registered a high of $172.8 million during Q3 2025, and its lowest value of $89.0 million during Q2 2022.
  • Moreover, its 3-year median value for Inventory Average was $128.3 million (2024), whereas its average is $132.5 million.
  • Its Inventory Average has fluctuated over the past 5 years, first fell by 3.61% in 2021, then spiked by 40.95% in 2024.
  • UNITED THERAPEUTICS's Inventory Average (Quarterly) stood at $95.2 million in 2021, then climbed by 1.31% to $96.5 million in 2022, then grew by 11.97% to $108.0 million in 2023, then skyrocketed by 40.95% to $152.3 million in 2024, then climbed by 22.07% to $172.8 million in 2025.
  • Its Inventory Average stands at $172.8 million for Q3 2025, versus $167.3 million for Q2 2025 and $161.7 million for Q1 2025.